These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 4839640)

  • 1. [Osteopathy in long-term hemodialysis (morphometric, physical-chemical and electron microscopic studies].
    Delling G; Azimi C; Donath K; Schulz A
    Verh Dtsch Ges Rheumatol; 1974; 3(0):176-7. PubMed ID: 4839640
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secondary hyperparathyroidism and pathological changes in the jaws of patients on long-term hemodialysis].
    Knezević G
    Chir Maxillofac Plast; 1984; 14(1):1-12. PubMed ID: 6594219
    [No Abstract]   [Full Text] [Related]  

  • 3. [Physiopathological problems of osteopathy in long term hemodialysis].
    Ritz E; Andrassy K; Krempien B; Lenhard V
    Med Welt; 1973 Apr; 24(14):517-22. PubMed ID: 4634139
    [No Abstract]   [Full Text] [Related]  

  • 4. Dialysis fracturing osteomalacia without hyperparathyroidism in patients treated with HCO3 rinsed Redy cartridge.
    Mion C; Branger B; Issautier R; Ellis HA; Rodier M; Shaldon S
    Trans Am Soc Artif Intern Organs; 1981; 27():634-8. PubMed ID: 7331146
    [No Abstract]   [Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic bone disease in patients on maintenance hemodialysis.
    Ritz E; Malluche H; Bommer J; Mehls O; Krempien B
    Nephron; 1974; 12(5):393-404. PubMed ID: 4824048
    [No Abstract]   [Full Text] [Related]  

  • 7. Case report 288: osteomalacia and secondary hyperparathyroidism (dialysis-induced), with aluminum deposition.
    Llewellyn CH; Resnik CS; Brower AC
    Skeletal Radiol; 1984; 12(3):223-6. PubMed ID: 6494942
    [No Abstract]   [Full Text] [Related]  

  • 8. Secondary hyperparathyroidism in patients on maintenance hemodialysis.
    Hida M
    Tokai J Exp Clin Med; 1982 Nov; 7(6):665-70. PubMed ID: 7184198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperparathyroidism in patients on long-term hemodialysis].
    Rodosskaia NK; Orlova II; Brazhnikova VV
    Klin Med (Mosk); 2009; 87(4):68-70. PubMed ID: 19514326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].
    Cournot-Witmer G; Gagnadoux MF; Lebon P; Broyer M; Balsan S
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():749-54. PubMed ID: 6762177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The calcium problem in long-term treatment with regular hemodialysis].
    Lindergård B
    Lakartidningen; 1980 Jun; 77(26-27):2421-3. PubMed ID: 6772896
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteomalacia in a hemodialysis patient receiving an active vitamin D sterol.
    Hernandez JD; Wesseling K; Boechat MI; Gales B; Salusky IB
    Nat Clin Pract Nephrol; 2007 Apr; 3(4):227-32. PubMed ID: 17389892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic hypercalcaemia of chronic dialysis.
    Feest TG; Newrick P; Read DJ
    Proc Eur Dial Transplant Assoc; 1983; 19():248-52. PubMed ID: 6348738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary hyperparathyroidism in patients on maintenance hemodialysis: study of the N and C-terminal parathyroid hormones.
    Hida M; Shimbo T; Nakamura K; Wakabayashi T; Saitoh H; Satoh T
    Tokai J Exp Clin Med; 1983 Jul; 8(3):225-8. PubMed ID: 6670108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Densitometric study of bone lesions due to hemodialysis].
    Laval-Jeantet M; Padovani M; Plainfossé MC; Fournier A; Bordier P; Tristant H; Bernard J
    J Radiol Electrol Med Nucl; 1971; 52(6):417-9. PubMed ID: 5122000
    [No Abstract]   [Full Text] [Related]  

  • 16. Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy.
    Jorna FH; Tobé TJ; Huisman RM; de Jong PE; Plukker JT; Stegeman CA
    Nephrol Dial Transplant; 2004 May; 19(5):1168-73. PubMed ID: 14993501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum aluminum in hemodialysis patients. Relation to osteodystrophy, encephalopathy and aluminum hydroxide consumption].
    Nielsen LP; Heaf JG
    Ugeskr Laeger; 1983 May; 145(18):1363-7. PubMed ID: 6868163
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspects of renal bone disease.
    Cochran M
    Aust N Z J Med; 1981; 11(Suppl 1):33-7. PubMed ID: 6942800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone diseases in hemodialysis patients].
    Nakazawa R
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():334-8. PubMed ID: 15250319
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperparathyroidism and dialysis vintage.
    Chertow GM; Plone M; Dillon MA; Burke SK; Slatopolsky E
    Clin Nephrol; 2000 Oct; 54(4):295-300. PubMed ID: 11076105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.